Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder

2005125 citationsJournal Article

Authors

These results suggest a possible augmentation role for aripiprazole when used in conjunction with SSRIs in SSRI-resistant MDD.

Good health and well-being

Published in: The Journal of Clinical Psychiatry

Volume 66, Issue 10, pp. 1326-1330

Field-Weighted Citation Impact: 14.02